Abstract
Purpose. The purpose of this study was to investigate in vivo biocompatibility, biodegradability and biological effects of contraceptive steroids, such as levonorgestrel and ethinyl estradiol, released from gels prepared with a combination of derivatized vegetable oil (Labrafil 1944 CS) and glyceryl ester of fatty acids (Precirol ATO 5).
Methods. Biocompatibility, biodegradability, and in vivo effects of levonorgestrel and ethinyl estradiol were studied by histologic evaluation of rat tissue, visual estimate of changes in gel size, and assessment of drug effects on reproductive cyclicity of female rats, respectively, following subcutaneous injection of gel formulations.
Results. Histological evaluation of the tissue samples following an injection of the gel revealed an inflammatory reaction for about 7 days, after which the tissues did not show any inflammatory response. Complete degradation of the gels containing 10% wax was observed between 5 and 6 weeks. Normal rat estrous cycles were completely blocked by the contraceptive steroids released from the gels. Gel formulations containing 0.25% w/w levonorgestrel were more effective in blocking the estrous cycle of female rats compared to the oil formulations containing an identical drug loading. The duration of the biological effect induced by levonorgestrel appears to be dose-related. The gel formulation containing 2.00% ethinyl estradiol was superior to oil formulation containing an identical drug loading in terms of controlling drug release and toxicity.
Conclusions. These observations suggest that Labrafil-Precirol gels are biocompatible and biodegradable. Moreover, controlled release of steroids is possible in vivo for a prolonged period of time.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
A. P. Sam. Controlled release contraceptive devices: a status report. J. Controlled Rel. 22(1):35–46 (1992).
F. Murad and J. A. Kuret. Estrogens and Progestins. In A. G. Gilman, L. S. Goodman and A. Gilman (eds.), The Pharmacological Basis of Therapeutics, MacMillan Publishing Co., Inc., New York, 1985, pp. 1384–1412.
D. Duchene and C. Vaution. Technologie pharmaceutique et contraception. Sci. Techn. Prat. Pharma. 2:644–660 (1986).
K. W. Leong and R. Langer. Polymeric controlled drug delivery. Adv. Drug Del. Rev. 1:199–233 (1987).
A. H. Nash. Controlled release systems for contraception. In R. Langer and D. Wise (eds.), Medical applications of controlled release. Vol. II, CRC Press, Boca Raton, Florida, USA, 1986, pp. 35–64.
A. P. Sam. Controlled-release contraceptives devices. In A. A. Hincal, S. Kas and M. Sumnu (eds.), Minutes of the Fifth Int. Pharm. Technol. Symp., Editions de Sante, Paris, 1990, pp. 271–284.
C. G. Nilsson, T. Luukkainen, J. Diaz and H. Allonen. Clinical performance of a new levonorgestrel releasing intrauterine device. A randomized comparison with a Nova-T copper device. Contraception 25:345–356 (1982).
T. Luukkainen and C. G. Nilsson. Sustained intrauterine release of d-norgestrel. Contraception 18:451–454 (1978).
H. Kurunmaki, J. Toivonen, P. Lahteenmaki and T. Luukkained. Intracervical release of levonorgestrel for contraception. Contraception 23:473–485 (1981).
H. B. Croxatto, S. Diaz, P. Miranda, K. Elamsson and E. D. B. Johansson. Plasma levels of levonorgestrel in women during longterm use of Norplant. Contraception 23:197–209 (1981).
P. T. Pietrow, W. Rinehart and J. C. Schmidt. IUDs—update on safety, effectiveness and research. Population reports, Series B, 3:49–94, May 1979.
K. Buckshee, S. Kumar and L. Saraya. Contraceptive vaginal ring—a rising star on the contraceptive horizon. Adv. Contraception 6:177–183 (1990).
L. R. Beck, D. R. Cowsar and D. H. Lewis. Systemic and local delivery of contraceptive steroids using biodegradable microcapsules. In E. Hafez, O. W. Van (eds.), Biodegradable Delivery Systems for Contraception, MTP Press, Lancaster, England, 1980, pp. 63–82.
D. L. Wise and A. C. Sharon and C. E. West. Preparation and evaluation of biodegradable cylindrical implants for fertility control. Final Report #2036 to PARFR on Contract 91 N, July 24, 1980, Dynatech R/D Co., Cambridge, MA.
D. L. Wise, H. Rosenkrantz, J. B. Gregory and H. J. Esber. Long-term controlled delivery of levonorgestrel in rats by means of small biodegradable cylinders. J. Pharm. Pharmacol. 32:399–403 (1980).
C. G. Pitt, M. M. Gratzl, A. R. Jeffcoat, R. Zweidinger and A. Schindler. Sustained drug delivery systems II: Factors affecting release rates from poly(e-caprolactone) and related biodegradable polyesters. J. Pharm. Sci. 68(12):1534–1538 (1979).
C. G. Pitt. The Controlled parenteral delivery of polypeptides and proteins. Int. J. Pharm. (Netherlands) 59(3):173–196 (1990).
K. A. Fults and T. P. Johnston. Sustained-release of urease from a poloxamer gel matrix. J. Parent. Sci. Tech. 44(2):58–65 (1990).
J. L. Zatz, J. P. Berry and D. A. Alderman. Gels. In H. A. Lieberman, M. M. Rieger and G. S. Banker (eds.), Pharmaceutical Dosage Forms: Dispersed Systems, Marcel Dekker, New York, 1988, Vol. 2, pp. 495–510.
F. H. Buckwalter. Repository penicillin compositions. U.S. Patent #2, 507, 193 (1950).
Z. H. Gao, A. J. Shukla, J. R. Johnson, and W. R. Crowley. Controlled release of a contraceptive steroid from biodegradable and injectable gel formulations: In-vitro evaluation. Pharm. Res. 12(6):857–863 (1995).
H. H. Feder. Estrous Cyclicity in Mammals. In N. T. Adler (eds.), Neuroendocrinology of Reproduction: Physiology and Behavior, Plenum Press, New York, 1981, pp. 279–348.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gao, Zh., Crowley, W.R., Shukla, A.J. et al. Controlled Release of Contraceptive Steroids from Biodegradable and Injectable Gel Formulations: In Vivo Evaluation. Pharm Res 12, 864–868 (1995). https://doi.org/10.1023/A:1016261004230
Issue Date:
DOI: https://doi.org/10.1023/A:1016261004230